Source: Clinical Trials Arena

Novotech: Novotech and Wonju Severance Christian Hospital sign MoU to boost trials

Novotech has signed a memorandum of understanding (MoU) with Wonju Severance Christian Hospital, aiming to boost clinical trials in Korea. The post Novotech and Wonju Severance Christian Hospital sign MoU to boost trials appeared first on Clinical Trials Arena.

Read full article »
Est. Annual Revenue
$100-500M
Est. Employees
1.0-5.0K
John Moller's photo - CEO of Novotech

CEO

John Moller

CEO Approval Rating

90/100

Read more